Country · Healthcare markets
South Africa healthcare markets
178 reports across 5 categories, with market size and growth to 2033.
South Africa healthcare markets178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023 · share of the world market
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
Bayer AG15 reports
IBM Watson Health13 reports
Each market name opens its South Africa report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| 3D Laparoscopy Imaging Systems | $21 Mn | $45 Mn | 7.9% | 0.7% | – |
| 3D Printed Implants | $23 Mn | $93 Mn | 14.7% | 0.7% | – |
| 3D Printing in Medical Application | $16 Mn | $110 Mn | 21.5% | 0.7% | – |
| Artificial Intelligence (AI) in Drugs Discovery | $4 Mn | $44 Mn | 27.3% | 0.7% | 4 |
| Artificial Intelligence (AI) in Healthcare | – | – | – | – | 9 |
| Artificial Intelligence (AI) in Life Sciences | $14 Mn | $168 Mn | 27.9% | 0.7% | 6 |
| Artificial Intelligence (AI) in Medical Imaging | $6 Mn | $61 Mn | 26.4% | 0.7% | 4 |
| Artificial Intelligence (AI) in Medicine | $54 Mn | $1.4 Bn | 38.7% | – | 9 |
| Artificial Intelligence (AI) in Pharma | – | – | – | – | 4 |
| Artificial Intelligence (AI) in Radiology | $4 Mn | $53 Mn | 29.8% | 0.7% | 3 |
| Artificial Intelligence (AI) in Remote Patient Monitoring | $6 Mn | $91 Mn | 31.6% | 0.7% | – |
| Artificial Intelligence (AI) Machine Learning(ML) in Healthcare | $12 Mn | $338 Mn | 39.2% | 0.6% | 9 |
| Blockchain in Genomics | $15 Mn | $405 Mn | 39.5% | 0.7% | – |
| Blockchain-as-a-Service | $14 Mn | $196 Mn | 30.5% | 0.7% | – |
| Brain Imaging, Biomarkers and NeuroInformatics | $4 Mn | $8 Mn | 5.9% | 0.6% | – |
| Brain PET-MRI Systems | $2 Mn | $5 Mn | 7.7% | 0.6% | – |
| Clinical Alarm Management | $11 Mn | $18 Mn | 4.5% | 0.6% | – |
| Clinical Data Management Systems | $16 Mn | $56 Mn | 13.1% | 0.7% | – |
| Connected Healthcare Market | $382 Mn | $4.6 Bn | 28.3% | 0.7% | – |
| Decentralized Clinical Trials(DCTs) | $11 Mn | $47 Mn | 16% | 0.7% | – |
| Dental 3D Printing | $22 Mn | $157 Mn | 21.7% | 0.6% | – |
| Dental CAD/CAM | $22 Mn | $63 Mn | 11.2% | 0.7% | – |
| Digital Biomarkers | $29 Mn | $653 Mn | 36.7% | 0.7% | – |
| Digital diabetes care | $83 Mn | $540 Mn | 20.5% | 0.7% | – |
| Digital Pathology Systems | $8 Mn | $31 Mn | 14.9% | 0.7% | – |
| Digital Therapeutics | $44 Mn | $329 Mn | 22.2% | 0.7% | – |
| Digital Twin | $11 Mn | $107 Mn | 25.5% | 0.6% | – |
| Digital X-ray | $113 Mn | $223 Mn | 7% | 0.7% | – |
| Electronic Health Record | $235 Mn | $398 Mn | 5.4% | 0.6% | – |
| Healthcare Information System | $1.9 Bn | $10.2 Bn | 18.3% | 0.7% | – |
| Healthcare IT | $3.1 Bn | $11.3 Bn | 13.6% | 0.6% | – |
| Home Healthcare | $2.4 Bn | $5.6 Bn | 9.1% | 0.7% | – |
| Internet Of Things In Healthcare | $647 Mn | $3.5 Bn | 18.2% | 0.7% | – |
| IoT in Healthcare | $1.2 Bn | $6.3 Bn | 18.3% | 0.7% | – |
| Long-term Care Software | $23 Mn | $83 Mn | 13.8% | 0.6% | – |
| Mental Health Apps | $36 Mn | $264 Mn | 21.9% | 0.7% | – |
| Pathology Imaging Systems | $11 Mn | $36 Mn | 13.1% | 0.6% | – |
| Point of Care Diagnostics | $295 Mn | $675 Mn | 8.6% | 0.7% | 127 |
| Remote Medication Management | $25 Mn | $135 Mn | 18.2% | 0.6% | – |
| Remote Patient Monitoring | $10 Mn | $59 Mn | 19% | 0.7% | – |
| Werable Healthcare Devices | $212 Mn | $1.4 Bn | 21% | 0.7% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Alopecia areata | – | – | – | – | – |
| Alzheimers Dignostic | $14 Mn | $30 Mn | 8.1% | 0.7% | – |
| Ambulance Service | $203 Mn | $453 Mn | 8.3% | 0.6% | – |
| Ambulatory Surgery Center | $260 Mn | $528 Mn | 7.3% | 0.7% | – |
| Antimicrobial Susceptibility Testing | – | – | – | – | – |
| Bioinformatics | $79 Mn | $339 Mn | 15.6% | 0.7% | – |
| Biomaterial Wound Dressing | $53 Mn | $114 Mn | 7.9% | 0.7% | – |
| Blood Gas and Electrolyte Analyzers | $18 Mn | $38 Mn | 7.6% | 0.7% | – |
| Bone Cancer Diagnostic | $7 Mn | $16 Mn | 8.6% | 0.7% | – |
| Brain Cancer Diagnostic | $10 Mn | $39 Mn | 14.8% | 0.6% | – |
| Breast Cancer Diagnostic | $27 Mn | $63 Mn | 9% | 0.6% | – |
| Clinical Laboratory Service | – | – | – | – | – |
| Dental Care Service | – | – | – | – | – |
| Dental Imaging | $22 Mn | $53 Mn | 9.1% | 0.7% | – |
| Dermatology Diagnostic | $169 Mn | $545 Mn | 12.4% | 0.7% | – |
| Fertility Service | $137 Mn | $277 Mn | 7.3% | 0.7% | – |
| Healthcare Electronic Data Interchange (EDI) | $26 Mn | $71 Mn | 10.6% | 0.7% | – |
| Healthcare In Vitro Diagnostic | $543 Mn | $887 Mn | 5% | 0.6% | – |
| Hospitals and Health Systems | $28.3 Bn | $54.8 Bn | 6.8% | 0.7% | – |
| Medical Billing | $29 Mn | $96 Mn | 12.6% | 0.6% | – |
| Medical Tourism | $482 Mn | $1.7 Bn | 13.4% | 0.7% | – |
| Nursing Education | $67 Mn | $163 Mn | 9.3% | 0.6% | – |
| Patient Support Programs (PSP) | $112 Mn | $539 Mn | 17% | 0.7% | – |
| Point Of Care (PoC) Molecular Diagnostic | $122 Mn | $331 Mn | 10.5% | 0.6% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Acute Care Needleless Connectors | $3 Mn | $7 Mn | 8.7% | 0.7% | – |
| Advanced Bipolar Direct Energy Devices | $20 Mn | $52 Mn | 9.9% | 0.7% | – |
| Aesthetic Lasers and Energy Devices | $11 Mn | $37 Mn | 13.3% | 0.6% | – |
| Air Ambulance Life Support Solutions | $29 Mn | $78 Mn | 10.3% | 0.7% | – |
| Airway Management Devices | $13 Mn | $24 Mn | 6.4% | 0.7% | – |
| Anastomosis Devices | $21 Mn | $44 Mn | 8% | 0.7% | – |
| Anesthesia & Respiratory Devices | $187 Mn | $517 Mn | 10.7% | 0.6% | – |
| Anesthesia Monitoring Devices | $17 Mn | $62 Mn | 13.7% | 0.7% | – |
| Angiography Devices | $81 Mn | $167 Mn | 7.5% | 0.6% | – |
| Angioplasty Balloons | $26 Mn | $43 Mn | 5% | 0.7% | – |
| Anti-Snoring Devices | $8 Mn | $21 Mn | 10% | 0.6% | – |
| Apheresis Equipments | $17 Mn | $34 Mn | 7.4% | 0.6% | – |
| Arrhythmia Monitoring Devices | $39 Mn | $75 Mn | 6.7% | 0.7% | – |
| Assisted Walking Aids | $15 Mn | $29 Mn | 6.7% | 0.6% | – |
| Audiology Devices | $51 Mn | $106 Mn | 7.6% | 0.7% | – |
| Defibrillator | $115 Mn | $230 Mn | 7.1% | 0.6% | – |
| Dental Articulators | $3 Mn | $5 Mn | 7.6% | 0.6% | – |
| Dental Caries Detectors | $2 Mn | $8 Mn | 13% | 0.6% | – |
| Dental Diagnostic and Surgical Equipments | $78 Mn | $173 Mn | 8.3% | 0.7% | – |
| Dental X-Ray Equipments | $11 Mn | $26 Mn | 8.4% | 0.7% | – |
| Diabetes Care Devices | $277 Mn | $551 Mn | 7.1% | 0.7% | – |
| Digital Diabetes Management | – | – | – | – | – |
| Direct Energy Medical Devices | $72 Mn | $131 Mn | 6.2% | 0.7% | – |
| Disposable Surgical Devices | $59 Mn | $133 Mn | 8.5% | 0.7% | – |
| Insulin Delivery Devices | $103 Mn | $218 Mn | 7.7% | 0.7% | – |
| Insulin Patch Pumps | $6 Mn | $20 Mn | 13.2% | 0.7% | – |
| Rehabilitation Equipments | $130 Mn | $264 Mn | 7.3% | 0.7% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Adaptogens | $53 Mn | $133 Mn | 9.7% | 0.6% | – |
| Amino Acid | – | – | – | – | – |
| Anthelmintic Drug | – | – | – | – | – |
| Antioxidants | – | – | – | – | – |
| Antipyretics OTC | – | – | – | – | – |
| BCAA Supplement | $9 Mn | $20 Mn | 7.9% | 0.7% | – |
| Beauty Supplements | $27 Mn | $72 Mn | 10.4% | 0.6% | – |
| Biotin Supplement | $3 Mn | $5 Mn | 6.2% | 0.7% | – |
| Bone & Joint Health Supplements | $78 Mn | $163 Mn | 7.6% | 0.7% | – |
| Calcium Supplements | $16 Mn | $33 Mn | 7.2% | 0.7% | – |
| Cannabidiol (CBD) Supplements | $34 Mn | $181 Mn | 18% | 0.6% | – |
| Cardiovascular Health Supplements | $44 Mn | $86 Mn | 6.9% | 0.7% | – |
| Clinical Nutrition | $185 Mn | $412 Mn | 8.3% | 0.6% | – |
| Coenzyme Q10 | $3 Mn | $9 Mn | 10.2% | 0.7% | – |
| Collagen Supplements | $14 Mn | $29 Mn | 7.3% | 0.7% | – |
| Creatine | $4 Mn | $8 Mn | 7.5% | 0.7% | – |
| Dietary Supplements | $2 Bn | $4.1 Bn | 7.4% | 0.7% | – |
| Eye Health Supplements | $20 Mn | $41 Mn | 7.4% | 0.7% | – |
| Functional Food | $1.9 Bn | $4 Bn | 7.9% | 0.7% | – |
| Hair Growth Supplements | $12 Mn | $27 Mn | 8.5% | 0.7% | – |
| Herbal Supplements | $533 Mn | $1.2 Bn | 8.8% | 0.7% | – |
| Immune Health Supplement | – | – | – | – | – |
| Iron Supplement | $13 Mn | $27 Mn | 7.7% | 0.7% | – |
| Men's Health Supplements | $118 Mn | $255 Mn | 8% | 0.7% | – |
| Mood and Stress Supplements | $68 Mn | $167 Mn | 9.3% | 0.6% | – |
| Nutritional Supplements | $2.5 Bn | $5.4 Bn | 8% | 0.7% | – |
| Omega 3 Fatty Acid | $27 Mn | $61 Mn | 8.6% | 0.6% | – |
| Oncology Nutrition | $14 Mn | $31 Mn | 8.5% | 0.7% | – |
| Osteoporosis Supplements | $20 Mn | $42 Mn | 7.7% | 0.7% | – |
| Over The Counter (OTC) Analgesics | $143 Mn | $225 Mn | 4.6% | 0.7% | – |
| Over The Counter (OTC) Antifungal | $16 Mn | $27 Mn | 5% | 0.7% | – |
| Over The Counter (OTC) Consumer | $982 Mn | $1.8 Bn | 6.4% | 0.7% | – |
| Over The Counter (OTC) Drugs | $1.2 Bn | $2.1 Bn | 5.9% | 0.7% | – |
| Over The Counter (OTC) Gastrointestinal Drugs | $36 Mn | $60 Mn | 5.1% | 0.7% | – |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | $94 Mn | $158 Mn | 5.3% | 0.7% | – |
| Over The Counter (OTC) Ophthalmic Drugs | $23 Mn | $41 Mn | 5.7% | 0.7% | – |
| Over The Counter (OTC) Pharmaceuticals | $1.2 Bn | $2.1 Bn | 5.9% | 0.7% | – |
| Over The Counter (OTC) Sleep Aid Products | $34 Mn | $57 Mn | 5.2% | 0.6% | – |
| Over The Counter (OTC) Vitamins and Minerals | $208 Mn | $399 Mn | 6.7% | 0.7% | – |
| Plant-Based Supplements | $80 Mn | $193 Mn | 9.2% | 0.7% | – |
| Prebiotics | $53 Mn | $179 Mn | 13% | 0.6% | – |
| Probiotic Supplements for Gut Health | $40 Mn | $89 Mn | 8.4% | 0.6% | – |
| Protein Supplement | $130 Mn | $298 Mn | 8.6% | 0.7% | – |
| Sports Nutrition | $338 Mn | $810 Mn | 9.1% | 0.7% | – |
| Vitamin B12(Cobalamin) | $2 Mn | $4 Mn | 6.7% | 0.7% | – |
| Vitamin D Supplements | – | – | – | – | – |
| Weight Management Supplement | – | – | – | – | – |
| Women's Health Supplements | $130 Mn | $281 Mn | 8% | 0.7% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Abuse Deterrent Opioids | – | – | – | – | – |
| Alexipharmic Drugs | – | – | – | – | – |
| Alopecia Drugs (Hair Loss) | – | – | – | – | – |
| Alzheimer Drugs | $33 Mn | $71 Mn | 8% | – | – |
| Aminoglycosides | – | – | – | – | – |
| Anemia Drugs | – | – | – | – | – |
| Anti-Aging | $573 Mn | $1.4 Bn | 9.3% | 0.7% | – |
| Anti-Depressants Drugs | $117 Mn | $172 Mn | 3.9% | 0.7% | – |
| Anti-Nerve Growth Factor | – | – | – | – | – |
| Anti-Venom | – | – | – | – | – |
| Anticoagulants | – | – | – | – | – |
| Antithrombotic Drugs | – | – | – | – | – |
| Artificial Skin | $16 Mn | $32 Mn | 7% | 0.7% | – |
| Asthma & COPD Drugs | $322 Mn | $536 Mn | 5.2% | 0.6% | – |
| Atherosclerosis Drugs | – | – | – | – | – |
| Atopic Dermatitis Drugs | $73 Mn | $257 Mn | 13.4% | 0.7% | – |
| Autologous Matrix-induced Chondrogenesis | – | – | – | – | – |
| Axial Spondyloarthritis (axSpA) | – | – | – | – | – |
| Biological Safety Testing | – | – | – | – | – |
| Biosimilar Monoclonal Antibodies | – | – | – | – | – |
| Biosimilars | $240 Mn | $2.4 Bn | 26.1% | 0.6% | – |
| Blood Plasma | – | – | – | – | – |
| Bone Marrow Aspirate Concentrates | – | – | – | – | – |
| Burn Care | – | – | – | – | – |
| Burn Ointment | – | – | – | – | – |
| Cancer Supportive Care Drugs | $161 Mn | $287 Mn | 5.9% | 0.7% | – |
| Cannabidiol (CBD) | $143 Mn | $752 Mn | 18% | 0.6% | – |
| Cannabis | $220 Mn | $871 Mn | 14.7% | 0.6% | – |
| Cell Based Immunotherapy | $108 Mn | $945 Mn | 24.2% | 0.7% | – |
| Contraceptives Drugs | $164 Mn | $355 Mn | 8% | 0.7% | – |
| Cord Blood Banking Service | $12 Mn | $26 Mn | 7.7% | 0.6% | – |
| Diabetes Management | $507 Mn | $1.1 Bn | 8.3% | 0.7% | – |
| Diabetic Retinopathy Drugs | $70 Mn | $141 Mn | 7.2% | 0.7% | – |
| Epilepsy Drugs | $62 Mn | $99 Mn | 4.7% | 0.7% | – |
| Gastroesophageal Reflux Disease (GERD) Drugs | $34 Mn | $47 Mn | 3.3% | 0.7% | – |
| Gastrointestinal Drugs | $351 Mn | $619 Mn | 5.8% | 0.7% | – |
| HIV Drugs | $195 Mn | $385 Mn | 7% | 0.7% | – |
| Oncology/Cancer Drugs | $1.2 Bn | $2.9 Bn | 9.6% | 0.7% | – |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.